DK0892802T3 - Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer - Google Patents

Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer

Info

Publication number
DK0892802T3
DK0892802T3 DK97908068T DK97908068T DK0892802T3 DK 0892802 T3 DK0892802 T3 DK 0892802T3 DK 97908068 T DK97908068 T DK 97908068T DK 97908068 T DK97908068 T DK 97908068T DK 0892802 T3 DK0892802 T3 DK 0892802T3
Authority
DK
Denmark
Prior art keywords
cyclopent
acetylcholinesterase
piperidines
spiro
indole
Prior art date
Application number
DK97908068T
Other languages
English (en)
Inventor
Gerard J O'malley
Mark G Palermo
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0892802T3 publication Critical patent/DK0892802T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK97908068T 1996-04-10 1997-03-10 Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer DK0892802T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63064196A 1996-04-10 1996-04-10
PCT/US1997/003864 WO1997037992A2 (en) 1996-04-10 1997-03-10 Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors

Publications (1)

Publication Number Publication Date
DK0892802T3 true DK0892802T3 (da) 2003-12-01

Family

ID=24527997

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97908068T DK0892802T3 (da) 1996-04-10 1997-03-10 Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer

Country Status (18)

Country Link
EP (1) EP0892802B1 (da)
JP (1) JP3615225B2 (da)
KR (1) KR100270145B1 (da)
CN (1) CN1233249A (da)
AR (1) AR006553A1 (da)
AT (1) ATE252581T1 (da)
AU (1) AU708124B2 (da)
BR (1) BR9708563A (da)
CA (1) CA2251545C (da)
DE (1) DE69725713T2 (da)
DK (1) DK0892802T3 (da)
ES (1) ES2207718T3 (da)
HU (1) HUP9902755A3 (da)
IL (1) IL126003A0 (da)
NO (1) NO984739L (da)
PT (1) PT892802E (da)
WO (1) WO1997037992A2 (da)
ZA (1) ZA972984B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1604653A1 (en) 1998-09-30 2005-12-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
AU2011216950A1 (en) 2010-02-16 2012-08-23 Pfizer Inc. (R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors
JP6790094B2 (ja) 2015-11-12 2020-11-25 エーエフエーエスシーアイ,インコーポレイテッド イオンチャネル阻害化合物、医薬製剤および使用
WO2020048828A1 (en) 2018-09-03 2020-03-12 Bayer Pharma Aktiengesellschaft 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds
WO2020048827A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds
WO2020048829A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 3,9-diazaspiro[5.5]undecane compounds

Also Published As

Publication number Publication date
AU708124B2 (en) 1999-07-29
DE69725713T2 (de) 2004-05-13
WO1997037992A2 (en) 1997-10-16
ZA972984B (en) 1997-11-03
NO984739L (no) 1998-12-09
AR006553A1 (es) 1999-09-08
NO984739D0 (no) 1998-10-09
CA2251545C (en) 2002-01-08
KR20000005328A (ko) 2000-01-25
PT892802E (pt) 2004-03-31
DE69725713D1 (de) 2003-11-27
BR9708563A (pt) 1999-08-03
IL126003A0 (en) 1999-04-11
JP2002509520A (ja) 2002-03-26
HUP9902755A3 (en) 2000-05-29
ATE252581T1 (de) 2003-11-15
KR100270145B1 (ko) 2000-11-01
AU1990997A (en) 1997-10-29
EP0892802B1 (en) 2003-10-22
JP3615225B2 (ja) 2005-02-02
CN1233249A (zh) 1999-10-27
ES2207718T3 (es) 2004-06-01
CA2251545A1 (en) 1997-10-16
EP0892802A1 (en) 1999-01-27
HUP9902755A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
NO962527L (no) Naftalenderivater, fremgangsmåter for deres fremstilling og mellomprodukter for dem
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO993003D0 (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK0950657T3 (da) Substituerede carbazoler, fremgangsmåde til deres fremstilling og deres anvendelse som sPLA2-inhibitorer
NO996115D0 (no) Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister
NO990246L (no) Akryloylsubstituert distamycinderivater, fremgangsmÕte til fremstilling av disse, og deres anvendelse som antitumor- og antivirusmidler
DK0912509T3 (da) Distamycinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som antitumor- og antivirale midler
DK0795547T3 (da) (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk
NO982708D0 (no) Nye fenylamidinderivater, fremgangsmÕte for fremstilling derav og deres anvendelse som legemidler
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
DK1015433T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oler, fremgangsmåder til fremstilling af disse og deres anvendelse som lægemidler
NO983860D0 (no) Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
NO951418D0 (no) Peptidderivater, deres fremstilling og anvendelse som terapeutika
NO984739D0 (no) Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer
DK0946579T3 (da) Nye forbindelser afledt af erythromcin, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
NO970682D0 (no) Diarylalkanderivater inneholdende en alisyklisk gruppe, deres fremstilling og deres terapeutiske og profylaktiske bruk
NO20020308D0 (no) Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten